|

nab-paclitaxel + cisplatin Clinical Trials

1 actively recruiting trial

Also known as: Chemotherapy

Pipeline

Phase 1/2: 1

Top Sponsors

  • Shanghai Chest Hospital1

Indications

  • Unresectable Locally Advanced Esophageal Cancer1
  • Esophageal Squamous Cell Carcinoma1
  • Cancer1

Other1 trial

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.